Zhuofeng Lin

2.8k total citations · 1 hit paper
45 papers, 2.2k citations indexed

About

Zhuofeng Lin is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Zhuofeng Lin has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Zhuofeng Lin's work include Fibroblast Growth Factor Research (20 papers), Kruppel-like factors research (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). Zhuofeng Lin is often cited by papers focused on Fibroblast Growth Factor Research (20 papers), Kruppel-like factors research (14 papers) and Liver Disease Diagnosis and Treatment (10 papers). Zhuofeng Lin collaborates with scholars based in China, Hong Kong and United States. Zhuofeng Lin's co-authors include Xiaokun Li, Aimin Xu, Shaoqiang Lin, Yu Wang, Leigang Jin, Xuebo Pan, Haishan Tian, Stefan R. Bornstein, Karen S.L. Lam and Nobuyuki Itoh and has published in prestigious journals such as Circulation, Immunity and PLoS ONE.

In The Last Decade

Zhuofeng Lin

45 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice

2013 567 citations Zhuofeng Lin, Shaoqiang Lin et al. profile →

Peers

Zhuofeng Lin

EPIDE

PHYSI

SURGE

CCM

Claire C. Bastie United Kingdom

Chaoyong He China

Birgit Knebel Germany

Raquel Fucho Spain

Gabriela Orasanu United States

Xuelian Xiong China

Sung‐E Choi South Korea

Tjeerd Sijmonsma Germany

Lucia Russo United States

Takafumi Senokuchi Japan

Claire C. Bastie United Kingdom

Zhuofeng Lin

966 ×0.7

338 ×0.6

EPIDE

542 ×1.4

PHYSI

224 ×1.0

SURGE

102 ×0.6

CCM

Citations per year, relative to Zhuofeng Lin Zhuofeng Lin (= 1×) peers Claire C. Bastie

Countries citing papers authored by Zhuofeng Lin

Since Specialization

Citations

This map shows the geographic impact of Zhuofeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuofeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuofeng Lin more than expected).

Fields of papers citing papers by Zhuofeng Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuofeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuofeng Lin. The network helps show where Zhuofeng Lin may publish in the future.

Co-authorship network of co-authors of Zhuofeng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuofeng Lin. A scholar is included among the top collaborators of Zhuofeng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuofeng Lin. Zhuofeng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meng, Fengzhen, Zhuofeng Lin, Yuxin Sun, et al.. (2025). A tissue regeneration-promoting hydrogel dressing incorporating zirconium MOF loaded with curcumin for multi-modal healing of bacterial-infected wounds. Materials Today Chemistry. 44. 102568–102568. 3 indexed citations

Aierken, Aili, et al.. (2025). Mesenchymal Stem Cells with Simultaneous Overexpression of GPX3 and CD47 for the Treatment of Drug-Induced Acute Liver Injury. Veterinary Sciences. 12(2). 149–149. 1 indexed citations

Li, Xiaoqian, Lihua Fang, Qian Chen, et al.. (2025). Cardiac FGF23 Increases Intracellular Calcium in Atrial Myocytes and the Susceptibility to Atrial Fibrillation Decreased in FGF23^f^/^fMyHC^Cre^/+ Mice. Journal of Cellular and Molecular Medicine. 29(6). e70517–e70517. 1 indexed citations

Lin, Zhuofeng, et al.. (2025). Visceral obesity and HFpEF: targets and therapeutic opportunities. Trends in Pharmacological Sciences. 46(4). 337–356. 2 indexed citations

Du, Hejun, et al.. (2025). Fibroblast Growth Factor 20 Attenuates Colitis by Restoring Impaired Intestinal Epithelial Barrier Integrity and Modulating Macrophage Polarization via S100A9 in an NF-κB-Dependent Manner. Cellular and Molecular Gastroenterology and Hepatology. 19(6). 101486–101486. 1 indexed citations

Shi, Yan‐Ping, Qiuyue Wang, Xihui Sheng, et al.. (2024). Dietary supplementation with lycopene improves semen quality and antioxidant status in breeder roosters. Poultry Science. 104(2). 104658–104658. 3 indexed citations

Nguyen, Thuy Thi Thanh, et al.. (2023). 2-Geranyl-1-methoxyerythrabyssin II alleviates lipid accumulation and inflammation in hepatocytes through AMPK activation and AKT inhibition. Archives of Pharmacal Research. 46(9-10). 808–824. 2 indexed citations

Gan, Jing, et al.. (2023). Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension. Frontiers in Cardiovascular Medicine. 10. 1168047–1168047. 3 indexed citations

Li, Dan, Yu Ning, Yu Yan, et al.. (2022). Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery. Frontiers in Cardiovascular Medicine. 9. 850517–850517. 5 indexed citations

10.

Lin, Zhuofeng, et al.. (2022). Ginsenoside Rh2 attenuates CDAHFD-induced liver fibrosis in mice by improving intestinal microbial composition and regulating LPS-mediated autophagy. Phytomedicine. 101. 154121–154121. 19 indexed citations

11.

Yang, Xiaoning, Ming Ni, Yali Zhang, et al.. (2020). Fibroblast growth factor 21 alleviates acute pancreatitis via activation of the Sirt1‐autophagy signalling pathway. Journal of Cellular and Molecular Medicine. 24(9). 5341–5351. 17 indexed citations

12.

Geng, Leiluo, Boya Liao, Leigang Jin, et al.. (2019). Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues. Cell Reports. 26(10). 2738–2752.e4. 152 indexed citations

13.

Wang, Hong, Yihui Shao, Saisai Zhang, et al.. (2017). CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice. Acta Biochimica et Biophysica Sinica. 49(6). 541–549. 22 indexed citations

14.

Jin, Leigang, Zhuofeng Lin, & Aimin Xu. (2016). Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk. Diabetes & Metabolism Journal. 40(1). 22–22. 40 indexed citations

15.

Lin, Zhuofeng, Fan Wu, Shaoqiang Lin, et al.. (2014). Adiponectin protects against acetaminophen-induced mitochondrial dysfunction and acute liver injury by promoting autophagy in mice. Journal of Hepatology. 61(4). 825–831. 108 indexed citations

16.

Wu, Fan, Leigang Jin, Tingting Lu, et al.. (2014). Serum CXCL16 as a Novel Marker of Renal Injury in Type 2 Diabetes Mellitus. PLoS ONE. 9(1). e87786–e87786. 30 indexed citations

17.

Lin, Zhuofeng, Qiyong Gong, Zhihong Zhou, et al.. (2011). Increased plasma CXCL16 levels in patients with chronic kidney diseases. European Journal of Clinical Investigation. 41(8). 836–845. 27 indexed citations

18.

Lin, Zhuofeng, Zhen Wu, Yanlong Liu, et al.. (2010). Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile. PLoS ONE. 5(12). e15534–e15534. 151 indexed citations

19.

Li, Xiaokun, Zhuofeng Lin, Yan Li, et al.. (2007). Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo. Cardiovascular Pathology. 16(2). 85–91. 17 indexed citations

20.

Lin, Zhuofeng. (2005). Protective effects of non-mitogenic human acidic fibroblast growth factor on hydrogen peroxide-induced damage to cardiomyocytesin vitro. World Journal of Gastroenterology. 11(35). 5492–5492. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact